| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6157632 | American Journal of Kidney Diseases | 2013 | 9 Pages |
Abstract
Treatment with sitagliptin or glipizide monotherapy was effective and well tolerated over 54 weeks in patients with type 2 diabetes and ESRD who were receiving dialysis.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Juan C. MD, Dalila MD, Carl E. MD, Lance MD, Lei PhD, Gregory T. PhD, Edward J. BS, Michael J. PhD, Keith D. MD, Barry J. MD, PhD,